| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reviews |
1 Department of Obstetrics and Gynecology, Münster University Hospital, Münster, Germany and 2 Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Requests for reprints: George W. Yip, Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, 4 Medical Drive, Block MD 10, Singapore 117597, Singapore. Phone: 65-6516-3206; Fax: 65-6778-7643; E-mail: georgeyip{at}nus.edu.sg.
Glycosaminoglycans are major constituents of the cancer cell surface and the tumor stroma. The heparan sulfate degrading enzyme heparanase, hyaluronan, and its receptor CD44 are up-regulated in breast cancer, generating a microenvironment that promotes tumor progression and metastasis. Recent experimental and clinical evidence shows that heparanase, hyaluronan, and CD44 regulate cancer cell proliferation, migration, and invasion, as well as tumor-associated angiogenesis and are correlated with patient survival. These findings suggest that they may be used as prognostic factors and targets for breast cancer treatment. (Cancer Res 2006; 66(21): 10233-7)
This article has been cited by other articles:
![]() |
C. J. Creighton, X. Li, M. Landis, J. M. Dixon, V. M. Neumeister, A. Sjolund, D. L. Rimm, H. Wong, A. Rodriguez, J. I. Herschkowitz, et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features PNAS, August 18, 2009; 106(33): 13820 - 13825. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L.T. Teoh, M. P. Fitzgerald, L. W. Oberley, and F. E. Domann Overexpression of Extracellular Superoxide Dismutase Attenuates Heparanase Expression and Inhibits Breast Carcinoma Cell Growth and Invasion Cancer Res., August 1, 2009; 69(15): 6355 - 6363. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Nott, Y. Huang, X. Li, B. R. Fluharty, X. Qiu, W. V. Welshons, S. Yeh, and M. Muyan Genomic Responses from the Estrogen-responsive Element-dependent Signaling Pathway Mediated by Estrogen Receptor {alpha} Are Required to Elicit Cellular Alterations J. Biol. Chem., May 29, 2009; 284(22): 15277 - 15288. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Ivanova, C. M.V. Goparaju, S. V. Ivanov, D. Nonaka, C. Cruz, A. Beck, F. Lonardo, A. Wali, and H. I. Pass Protumorigenic Role of HAPLN1 and Its IgV Domain in Malignant Pleural Mesothelioma Clin. Cancer Res., April 15, 2009; 15(8): 2602 - 2611. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Nikolova, C.-Y. Koo, S. A. Ibrahim, Z. Wang, D. Spillmann, R. Dreier, R. Kelsch, J. Fischgrabe, M. Smollich, L. H. Rossi, et al. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression Carcinogenesis, March 1, 2009; 30(3): 397 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Y. W. Bourguignon, W. Xia, and G. Wong Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates {beta}-Catenin Signaling and NF{kappa}B-specific Transcription Activity Leading to MDR1 and Bcl-xL Gene Expression and Chemoresistance in Breast Tumor Cells J. Biol. Chem., January 30, 2009; 284(5): 2657 - 2671. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Becerra, L. A. Perez-Mediavilla, J. E. Weldon, S. Locatelli-Hoops, P. Senanayake, L. Notari, V. Notario, and J. G. Hollyfield Pigment Epithelium-derived Factor Binds to Hyaluronan: MAPPING OF A HYALURONAN BINDING SITE J. Biol. Chem., November 28, 2008; 283(48): 33310 - 33320. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chiron, I. Bekeredjian-Ding, C. Pellat-Deceunynck, R. Bataille, and G. Jego Toll-like receptors: lessons to learn from normal and malignant human B cells Blood, September 15, 2008; 112(6): 2205 - 2213. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ganesh, M. Gonzalez-Edick, D. Gibbons, M. Van Roey, and K. Jooss Intratumoral Coadministration of Hyaluronidase Enzyme and Oncolytic Adenoviruses Enhances Virus Potency in Metastatic Tumor Models Clin. Cancer Res., June 15, 2008; 14(12): 3933 - 3941. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Wallach-Dayan, A. M. Rubinstein, C. Hand, R. Breuer, and D. Naor DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis Mol. Cancer Ther., June 1, 2008; 7(6): 1615 - 1623. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, S. L Nott, Y. Huang, R. Hilf, R. A Bambara, X. Qiu, A. Yakovlev, S. Welle, and M. Muyan Gene expression profiling reveals that the regulation of estrogen-responsive element-independent genes by 17{beta}-estradiol-estrogen receptor {beta} is uncoupled from the induction of phenotypic changes in cell models J. Mol. Endocrinol., May 1, 2008; 40(5): 211 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Maxwell, J. McCarthy, and E. Turley Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J. Cell Sci., April 1, 2008; 121(7): 925 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Golshani, L. Lopez, V. Estrella, M. Kramer, N. Iida, and V. B. Lokeshwar Hyaluronic Acid Synthase-1 Expression Regulates Bladder Cancer Growth, Invasion, and Angiogenesis through CD44 Cancer Res., January 15, 2008; 68(2): 483 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Karihtala, Y. Soini, P. Auvinen, R. Tammi, M. Tammi, and V.-M. Kosma Hyaluronan in Breast Cancer: Correlations With Nitric Oxide Synthases and Tyrosine Nitrosylation J. Histochem. Cytochem., December 1, 2007; 55(12): 1191 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ouhtit, Z. Y. Abd Elmageed, M. E. Abdraboh, T. F. Lioe, and M. H.G. Raj In Vivo Evidence for the Role of CD44s in Promoting Breast Cancer Metastasis to the Liver Am. J. Pathol., December 1, 2007; 171(6): 2033 - 2039. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cohen, B. Maly, I. Simon, A. Meirovitz, E. Pikarsky, E. Zcharia, T. Peretz, I. Vlodavsky, and M. Elkin Tamoxifen Induces Heparanase Expression in Estrogen Receptor Positive Breast Cancer Clin. Cancer Res., July 15, 2007; 13(14): 4069 - 4077. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Hamilton, S. F. Fard, F. F. Paiwand, C. Tolg, M. Veiseh, C. Wang, J. B. McCarthy, M. J. Bissell, J. Koropatnick, and E. A. Turley The Hyaluronan Receptors CD44 and Rhamm (CD168) Form Complexes with ERK1,2 That Sustain High Basal Motility in Breast Cancer Cells J. Biol. Chem., June 1, 2007; 282(22): 16667 - 16680. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |